Fennec Pharmaceuticals Inc.
NASDAQ:FENC
Overview | Financials
Company Name | Fennec Pharmaceuticals Inc. |
Symbol | FENC |
Currency | USD |
Price | 4.36 |
Market Cap | 119,288,292 |
Dividend Yield | 0% |
52-week-range | 4.09 - 11.92 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Mr. Rostislav Raykov |
Website | https://www.fennecpharma.com |
An error occurred while fetching data.
About Fennec Pharmaceuticals Inc.
Fennec Pharmaceuticals Inc. operates as a biopharmaceutical company. Its product candidate in the clinical stage of development is PEDMARK, a formulation of sodium thiosulfate for the prevention of platinum-induced ototoxicity in pediatric cancer patients. The company was formerly known as Adherex Technologies Inc. and changed its name to Fennec Pharmaceuticals
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD